These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2138573)

  • 21. Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins.
    Caspi E; Ron-El R; Golan A; Nachum H; Herman A; Soffer Y; Weinraub Z
    Fertil Steril; 1989 Jan; 51(1):95-9. PubMed ID: 2521328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of the use of a pure urinary FSH stimulation regime in patients unsuccessfully treated with hMG in an in vitro fertilization program.
    Grillo M; Buck S; Freys I; Mettler L
    Gynecol Obstet Invest; 1989; 28(4):169-73. PubMed ID: 2533578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Increased risk of early pregnancy loss and lower live birth rate with GNRH antagonist vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation].
    Kdous M; Chaker A; Bouyahia M; Zhioua F; Zhioua A
    Tunis Med; 2009 Dec; 87(12):834-42. PubMed ID: 20209851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.
    Waxman J; Man A; Hendry WF; Whitfield HN; Besser GM; Tiptaft RC; Paris AM; Oliver RT
    Br Med J (Clin Res Ed); 1985 Nov; 291(6506):1387-8. PubMed ID: 2933122
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased fertilization and pregnancy rate in polypronuclear fertilization cycles in in vitro fertilization-embryo transfer.
    Golan A; Nachum H; Herman A; Ron-el R; Soffer Y; Caspi E
    Fertil Steril; 1992 Jan; 57(1):139-42. PubMed ID: 1530923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Premature luteinization and its treatment with an LH/RH analog].
    Schurz B; Egarter C; Manavi M; Huber JC
    Gynakol Rundsch; 1988; 28 Suppl 2():180-2. PubMed ID: 2976721
    [No Abstract]   [Full Text] [Related]  

  • 28. Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration.
    Friedler S; Raziel A; Schachter M; Strassburger D; Bukovsky I; Ron-El R
    Hum Reprod; 1999 Aug; 14(8):1944-8. PubMed ID: 10438404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Midluteal gonadotropin-releasing hormone analog administration in early pregnancy.
    Ron-El R; Golan A; Herman A; Raziel A; Soffer Y; Caspi E
    Fertil Steril; 1990 Mar; 53(3):572-4. PubMed ID: 2137797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of ovarian hyperstimulation syndrome.
    Amso NN; Shaw RW; Ahuja KK; Morris N
    Fertil Steril; 1991 Jan; 55(1):220-1. PubMed ID: 1986965
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention.
    Forman RG; Frydman R; Egan D; Ross C; Barlow DH
    Fertil Steril; 1990 Mar; 53(3):502-9. PubMed ID: 2106456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study.
    Giles J; Requena A; García-Velasco JA; Pacheco A; Pellicer J; Pellicer A
    Fertil Steril; 2009 Apr; 91(4 Suppl):1366-9. PubMed ID: 18692821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadotropin releasing hormone antagonists and cryopreservation outcome: a review.
    Nikolettos N; Asimakopoulos B; Simopoulou M; Al-Hasani S; Diedrich K
    Arch Gynecol Obstet; 2004 Sep; 270(2):69-73. PubMed ID: 14749941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Luteinizing-hormone-releasing hormone agonist treatment in patients with previously failed folliculogenesis during in vitro fertilization therapy.
    MacLachlan V; Besanko M; Wade H; Morrow L; O'Shea F; Trounson A; Healy D
    Ann N Y Acad Sci; 1988; 541():60-74. PubMed ID: 2973764
    [No Abstract]   [Full Text] [Related]  

  • 35. Medical reversible castration with D-Trp-6-LH-RH microcapsules for the treatment of endometriosis. Preliminary results in a series of 51 patients.
    Zorn JR; Soubrane O; Siboni O; Papageorgiou G
    Contrib Gynecol Obstet; 1987; 16():254-9. PubMed ID: 2961507
    [No Abstract]   [Full Text] [Related]  

  • 36. Do analogues of gonadotrophin releasing hormone influence follicular fluid steroid levels, oocyte maturity and fertilization rates?
    Tavmergen E; Tavmergen EN; Capanoğlu R
    Hum Reprod; 1992 Apr; 7(4):479-82. PubMed ID: 1387881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial of three luteinizing hormone-releasing hormone analogues used for ovarian stimulation in an in vitro fertilization program.
    Parinaud J; Oustry P; Perineau M; Rème JM; Monroziès X; Pontonnier G
    Fertil Steril; 1992 Jun; 57(6):1265-8. PubMed ID: 1534774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired corpus luteum function and other undesired results of pregnancies associated with inadvertent administration of a long-acting agonist of gonadotrophin-releasing hormone.
    Herman A; Ron-El R; Golan A; Nachum H; Soffer Y; Caspi E
    Hum Reprod; 1992 Apr; 7(4):465-8. PubMed ID: 1325988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.
    Orvieto R; Kruchkovich J; Rabinson J; Zohav E; Anteby EY; Meltcer S
    Fertil Steril; 2008 Jul; 90(1):228-30. PubMed ID: 17681292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression with gonadotropin-releasing hormone analogues prior to stimulation with gonadotropins: comparison of three protocols.
    Lipitz S; Ben-Rafael Z; Dor J; Shalev J; Elenbogen A; Levran D; Serr DM; Mashiach S
    Gynecol Obstet Invest; 1989; 28(1):31-4. PubMed ID: 2528497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.